Web Results



Omalizumab, sold under the trade name Xolair, is a humanized antibody originally designed to reduce sensitivity to inhaled or ingested allergens, especially in ...

Xolair Label - FDA


A Xolair vial contains 202.5 mg of Omalizumab, 145.5 mg ... After SC administration, Omalizumab is absorbed with an average absolute bioavailability of. 62%.

Omalizumab Injection: MedlinePlus Drug Information


Feb 15, 2015 ... Omalizumab injection may cause serious or life-threatening allergic reactions. You may experience an allergic reaction immediately after ...

Xolair Prescribing Information - Genentech


XOLAIR® (omalizumab) for injection, for subcutaneous use ..... For injection: 150 mg of omalizumab as lyophilized, sterile powder in a single-use 5 mL vial.

Omalizumab for Asthma — NEJM


Clinical Therapeutics from The New England Journal of Medicine — Omalizumab for Asthma.

omalizumab, Xolair: Drug Facts, Side Effects and Dosing


Information about omalizumab (Xolair), an injectable drug prescribed to treat asthma that is not adequately controlled with inhaled steroids.

Omalizumab: A Monoclonal Anti-IgE Antibody - Medscape


Omalizumab has demonstrated efficacy in children, adults, and adolescents with uncontrolled moderate to severe allergic asthma and allergic rhinitis.

DrugBank: Omalizumab


Omalizumab as Initial Therapy for a Patient on Prednisone and Having Mild Bilateral Wheezing. Michael A. Kaliner, MD, Medscape, 2005. MEDLINE Abstracts: ...

Preseasonal treatment with either omalizumab or an inhaled ...


Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost .... The fall exacerbation rate was significantly lower in the omalizumab versus ...

Omalizumab (Professional Patient Advice) - Drugs.com


Professional guide for Omalizumab. Includes: pharmacology, pharmacokinetics, contraindications, interactions, adverse reactions and more.

More Info

Xolair (Omalizumab): Side Effects, Interactions, Warning, Dosage ...


Learn about Xolair (Omalizumab) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.

Allergic Asthma and CIU Treatment | XOLAIR® (Omalizumab)


XOLAIR® (omalizumab) is a treatment for moderate to severe persistent allergic asthma and Chronic Idiopathic Urticaria (CIU) in appropriate patients.

FDA Approves Genentech's Xolair® (omalizumab)


Media. Thursday, Jul 7, 2016. FDA Approves Genentech's Xolair<sup>®</sup> (omalizumab) for Allergic Asthma in Children. Approval makes Xolair the only biologic for ...